TG Therapeutics, Inc

(NASDAQ:TGTX)

Latest On TG Therapeutics, Inc (TGTX):

Date/Time Type Description Signal Details
2023-05-06 07:44 ESTNewsTG Therapeutics' Stock Surge: Exploring The Factors And Exercising Caution (Rating Upgrade)N/A
2023-05-02 02:37 ESTNewsTG Therapeutics jumps 19% to hit 52-week high after Q1 beat (update)N/A
2023-05-01 14:23 ESTNewsTG Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $7.8M beats by $4.42MN/A
2023-05-01 14:23 ESTNewsTG Therapeutics slips despite Q1 beatN/A
2023-05-01 14:22 ESTNewsTG Therapeutics, Inc. (TGTX) Q1 2023 Earnings Call TranscriptN/A
2023-04-29 00:22 ESTNewsTG Therapeutics: A Plethora Of Good News, Strong Revenues ExpectedN/A
2023-04-27 23:34 ESTNewsTG Therapeutics gains after reimbursement win for multiple sclerosis therapyN/A
2023-04-11 19:18 ESTNewsTG Therapeutics extends rally to hit 52-week high after B. Riley commentsN/A
2023-04-11 19:18 ESTNewsHot Stocks: TLRY drops on earnings; MARA, MSTR, RIOT, COIN boosted by crypto rise; PSMT gains; MRNA fallsN/A
2023-04-11 04:01 ESTNewsTG Therapeutics jumps 22% as Cantor cites strong Briumvi salesN/A
2023-03-31 11:03 ESTNewsTG Therapeutics' multiple sclerosis drug Briumvi gets EMA panel backingN/A
2023-03-22 17:59 ESTNewsTG Therapeutics' Briumvi Has Potential For Growth In A Crowded MarketN/A
2023-03-20 19:43 ESTNewsTG Therapeutics: That ICER Report Doesn't Bother MeN/A
2023-03-09 23:16 ESTNewsTG Therapeutics’ price for multiple sclerosis therapy is not low enough - ICERN/A
2023-03-01 01:53 ESTNewsTG Therapeutics, Inc. (TGTX) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 10:24 ESTNewsTG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52MN/A
2023-02-27 20:17 ESTNewsTG Therapeutics Q4 2022 Earnings PreviewN/A
2023-02-23 20:12 ESTNewsTG Therapeutics' Briumvi: A Tough Sell For Multiple Sclerosis Treatment MarketN/A
2023-02-07 11:09 ESTNewsTG Therapeutics up as Cantor sees a “strong launch” for multiple sclerosis therapyN/A
2023-02-01 21:47 ESTNewsTG Therapeutics: Strategy After Briumvi LaunchN/A
2023-01-26 12:41 ESTNewsTG Therapeutics launches newly approved multiple sclerosis therapyN/A
2023-01-11 14:59 ESTNewsTG Therapeutics adds 10% to extend gains after insider purchaseN/A
2023-01-02 17:51 ESTNewsTG Therapeutics: Ramifications Of Briumvi ApprovalN/A
2022-12-29 23:50 ESTNewsTG Therapeutics surges as focus turns to launch of new multiple sclerosis therapyN/A
2022-12-28 18:27 ESTNewsTG Therapeutics jumps 19% as FDA approves multiple sclerosis therapyN/A
2022-12-24 22:09 ESTNewsStocks To Watch: Nio, Tesla And Hopes For A Santa Clause RallyN/A
2022-12-17 21:07 ESTNewsIt's almost 2023, but here are the drugs the FDA could approve before the end of the yearN/A
2022-12-15 16:42 ESTNewsTG Therapeutics: Ublituximab Could Achieve $1 Billion In Annual Sales By Year-End 2024N/A
2022-12-14 23:31 ESTNewsTG Therapeutics: Would Santa Deliver An Early Present?N/A
2022-11-13 05:29 ESTNewsTG Therapeutics (TGTX) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 23:59 ESTNewsTG Therapeutics GAAP EPS of -$0.26 beats by $0.07, revenue of $0.09M misses by $1.61MN/A
2022-11-10 23:59 ESTNewsTG Therapeutics jumps 56% amid FDA labeling talks for multiple sclerosis therapyN/A
2022-10-09 13:35 ESTNewsTG Therapeutics: Elucidating The Upcoming BinaryN/A
2022-09-21 15:15 ESTNewsTG Therapeutics: We Are Just Hanging In ThereN/A
2022-08-25 19:03 ESTNewsTG Therapeutics announces peer-reviewed publication of multiple sclerosis phase 3 trialsN/A
2022-08-09 08:40 ESTNewsTG Therapeutics stock soars 18% on Q2 beat as net loss narrows; eyes MS drug win by year-endN/A
2022-08-09 08:40 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 09:01 ESTNewsTG Therapeutics GAAP EPS of -$0.30 beats by $0.17, revenue of $0.6M beats by $0.42MN/A
2022-08-06 00:27 ESTNewsTG Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-09 02:04 ESTNewsTG Therapeutics And Ublituximab: From Icing To LifelineN/A
2022-06-01 21:32 ESTNewsTG Therapeutics slips as FDA withdraws approval for cancer drugN/A
2022-05-31 12:26 ESTNewsTG Therapeutics announces delay in FDA review for multiple sclerosis drugN/A
2022-05-21 18:22 ESTNewsTG Therapeutics initiated at BofA with a bearish view on multiple sclerosis drugN/A
2022-04-22 18:32 ESTNewsTG Therapeutics: Can The Company Successfully Turn Around?N/A
2022-04-18 21:06 ESTNewsTG Therapeutics: I May Double Down AgainN/A
2022-04-18 21:06 ESTNewsTG Therapeutics extends losses as H.C. Wainwright slashes target on Ukoniq setbackN/A
2022-04-18 06:43 ESTNewsTG Therapeutics stock falls 24% as it withdraws Ukoniq from sale, pulls filing with FDAN/A
2022-03-03 18:32 ESTNewsTG Therapeutics stock falls as FDA extends review of blood cancer drug comboN/A
2022-03-01 13:48 ESTNewsTG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08MN/A
2022-03-01 13:47 ESTNewsTG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q4 2021 Results - Earnings Call TranscriptN/A

About TG Therapeutics, Inc (TGTX):

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand 1 (PD-L1) and blocks its interactions with PD-1 and B7.1 receptors; TG-1701 is an orally available and covalently-bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK compared to ibrutinib in in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. In addition, it has various licensed preclinical programs for BET, interleukin-1 receptor associated kinase-4, and GITR; and collaboration agreements with Checkpoint Therapeutics, Inc., Jiangsu Hengrui Medicine Co., Novimmune SA, Ligand Pharmaceuticals Incorporated, and Jubilant Biosys. The company has strategic alliances with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Rhizen Pharmaceuticals, S A. The company is headquartered in New York, New York.

See Advanced Chart

General

  • Name TG Therapeutics, Inc
  • Symbol TGTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 272
  • Last Split Factor100:5625
  • Last Split Date2012-04-30
  • Fiscal Year EndDecember
  • IPO Date1995-12-14
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.tgtherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 36580.51
  • Price/Book (Most Recent Quarter) 13.05
  • Enterprise Value Revenue 40882.96
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.06
  • Next Year EPS Estimate -$0.80
  • Next Quarter EPS Estimate -$0.50
  • Operating Margin -179996%
  • Return on Assets -43%
  • Return on Equity -100%
  • Revenue 152000
  • Earnings Per Share -$1.96
  • Revenue Per Share $0
  • Gross Profit 152000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 6.47 billion
  • EBITDA -158616992
  • PE Ratio 37.85
  • Analyst Target Price $75.33
  • Book Value Per Share $4.00
View More

Share Statistics

  • Shares Outstanding 137.81 million
  • Shares Float 120.36 million
  • % Held by Insiders 713%
  • % Held by Institutions 67.24%
  • Shares Short 11.84 million
  • Shares Short Prior Month 11.76 million
  • Short Ratio 8
  • Short % of Float 10%
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 2.13
  • 52 Week High $56.74
  • 52 Week Low $7.12
  • 50 Day Moving Average 46.97
  • 200 Day Moving Average 37.82
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

TG Therapeutics, Inc (TGTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

TG Therapeutics, Inc (TGTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$38000-$0.72-$0.58-23.78%
2020-09-302020-11-09$N/A-$0.73-$0.41-76.76%
2020-06-302020-08-10$N/A-$0.47-$0.34-39.05%
2020-03-312020-05-11$38000-$0.48-$0.36-34.08%
2019-12-312020-03-02$38000-$0.44-$0.42-5.39%
2019-09-302019-11-12$38000-$0.69-$0.34-104.44%
2019-06-302019-08-09$38000-$0.42-$0.444.55%
2019-03-312019-05-10$38000-$0.43-$0.441.15%
2018-12-312019-03-01$38000-$0.69-$0.44-55.41%
2018-09-302018-11-09$38000-$0.43-$0.5420.37%
2018-06-302018-08-07$38000-$0.59-$0.53-12.38%
2018-03-312018-05-08$38000-$0.59-$0.44-34.09%
2017-12-312018-03-08$38000-$0.46-$0.44-4.14%
2017-09-302017-11-08$38000-$0.48-$0.43-11.63%
2017-06-302017-08-09$38000-$0.45-$0.43-5.26%
2017-03-312017-05-05$38000-$0.52-$0.41-27.45%
2016-12-312017-03-10$38000-$0.48-$0.36-33.33%
2016-09-302016-11-07$38000-$0.50-$0.31-61.29%
2016-06-302016-08-08$38000-$0.33-$0.29-15.79%
2016-03-312016-05-10$38000-$0.28-$0.3621.5%
2015-12-312016-03-07$38000-$0.37-$0.32-16.83%
2015-09-302015-11-09$38000-$0.28-$0.3417.65%
2015-06-302015-08-10$38000-$0.38-$0.30-26.67%
2015-03-312015-05-04$38000-$0.39-$0.33-18.18%
2014-12-312015-03-11$38000-$0.48-$0.26-84.62%
2014-09-302014-11-10$38000-$0.51-$0.32-59.38%
2014-06-302014-07-21$38000-$0.32-$0.24-33.33%
2014-03-312014-05-12$38000-$0.25-$0.18-38.89%
2013-12-312014-03-05$38000-$0.19-$0.17-11.76%
2013-09-302013-11-11$38000-$0.16-$0.2227.27%
2013-06-302013-08-01$38000-$0.29-$0.16-81.25%
2013-03-312013-05-14$38000-$0.17-$0.15-13.33%
2012-12-312013-03-12$19000-$0.12-$0.137.69%
2012-09-302012-11-08$N/A-$0.16-$0.12-33.33%
2012-06-302012-08-09$N/A-$0.16-$0.06-166.67%
2012-03-312012-05-21$N/A-$2.03
2011-09-302011-11-14$N/A-$9.05
2011-06-302011-08-15$N/A-$64.63
2011-03-312011-05-23$N/A$84.58
2010-12-312011-03-02$N/A$9.18
2010-09-302010-11-15$N/A$0.96
2010-06-302010-08-16$N/A$43.21
2010-03-312010-05-24$N/A-$54.27
2009-12-312010-03-03$N/A-$8.88
2009-09-302009-11-16$N/A-$16.57
2009-06-302009-08-14$N/A-$55.45
2009-03-312009-05-19$N/A-$30.34
2008-12-312009-02-25$N/A$5.06
2008-09-302008-12-03$N/A-$55.53
2008-06-302008-08-19$N/A-$56.64
2008-03-312008-05-20$N/A-$62.10
2007-09-302007-11-14$N/A-$112.50-$28.12-300.07%
2007-06-302007-07-09$N/A-$112.50-$84.37-33.34%
2007-03-312007-05-15$N/A-$119.73
2006-09-302006-11-14$N/A-$84.37-$84.370%
2006-06-302006-08-14$N/A-$112.50-$112.500%
2006-03-312006-05-15$N/A-$140.62-$140.620%
2005-09-302005-09-30$N/A-$118.85
2005-06-302005-06-30$N/A-$934.25
2005-03-312005-03-31$N/A-$152.43
2004-12-312004-12-31$N/A-$196.87
2004-09-302004-09-30$N/A-$240.39
2004-06-302004-06-30$N/A-$109.61
2004-03-312004-03-31$N/A-$140.65
2003-12-312003-12-31$N/A-$225.00
2003-09-302003-09-30$N/A-$391.61
2003-06-302003-06-30$N/A-$93.46
2003-03-312003-03-31$N/A-$91.67
2002-09-302002-09-30$N/A-$507.41
2002-06-302002-06-30$N/A$24.21
2002-03-312002-03-31$N/A-$552.10
2001-09-302001-09-30$N/A-$1,528.45
2001-06-302001-06-30$-2712000-$4,513.55
2001-03-312001-03-31$2.71 million$1,855.58
2000-09-302000-09-30$1.07 million-$2,621.34
2000-06-302000-06-30$1.44 million-$7,888.48
2000-03-312000-03-31$925000-$5,766.57
1999-09-301999-09-30-$986.48
1999-06-301999-06-30-$1,929.43
1999-03-311999-03-31-$2,666.06
1998-09-301998-09-30-$5,140.91
1998-06-301998-06-30$695.14
1998-03-311998-03-31-$9,885.89

TG Therapeutics, Inc (TGTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

TG Therapeutics, Inc (TGTX) Chart:

TG Therapeutics, Inc (TGTX) News:

Below you will find a list of latest news for TG Therapeutics, Inc (TGTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

TG Therapeutics, Inc (TGTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-01-1610CALL0 40TRUE00
2026-01-1620CALL0 00TRUE00
2026-01-16326.67CALL0 230TRUE00
2026-01-16425.93CALL0 1120TRUE00
2026-01-16526.72CALL0 6660TRUE00
2026-01-16822.7CALL0 2310TRUE00
2026-01-161019.5CALL0 2230TRUE00
2026-01-161217.57CALL0 3000TRUE00
2026-01-161514.2CALL1 6480TRUE14.20
2026-01-16160CALL0 00TRUE00
2026-01-161712.21CALL4 4850TRUE0.070.01
2026-01-161813.8CALL0 1330TRUE00
2026-01-161912.34CALL0 310TRUE00
2026-01-16209.48CALL12 2195202.12TRUE9.480
2026-01-16219CALL0 1020TRUE00
2026-01-16227.97CALL317 994193.36TRUE0.570.08
2026-01-162310.4CALL0 7373.94TRUE00
2026-01-16247.4CALL0 11099.99TRUE00
2026-01-16255.5CALL0 1643109.16TRUE00
2026-01-16263.75CALL0 850TRUE00
2026-01-16273.61CALL0 5686.39TRUE00
2026-01-16282.2CALL7 46746.63TRUE0.050.02
2026-01-16291.8CALL6 21491.96TRUE0.30.2
2026-01-16301.4CALL290 321869.18FALSE0.250.22
2026-01-16311CALL89 50369.89FALSE0.160.19
2026-01-16320.75CALL22 85573.43FALSE0.180.32
2026-01-16330.5CALL30 79772.77FALSE0.10.25
2026-01-16340.35CALL11 40774.3FALSE00
2026-01-16350.25CALL43 418576.34FALSE00
2026-01-16360.17CALL6 103877.29FALSE0.020.13
2026-01-16370.25CALL0 52089.01FALSE00
2026-01-16380.26CALL37 1408103.62FALSE0.260
2026-01-16390.24CALL0 72137.72FALSE00
2026-01-16400.1CALL324 341196.86FALSE0.010.11
2026-01-16410.22CALL0 39158.32FALSE00
2026-01-16420.1CALL0 163118.32FALSE00
2026-01-16430.2CALL0 187115.38FALSE00
2026-01-16440.15CALL0 14282.28FALSE00
2026-01-16450.05CALL2 1630113.25FALSE0.050
2026-01-16460.2CALL0 10298.56FALSE00
2026-01-16470.05CALL2 194123.08FALSE0.050
2026-01-16480.05CALL0 59152.85FALSE00
2026-01-16490CALL0 0320.93FALSE00
2026-01-16500.04CALL39 1584132.65FALSE-0.02-0.33
2026-01-16550.22CALL0 669236.41FALSE00
2026-01-16600.04CALL0 1009193.83FALSE00
2026-01-1610.05PUT2 4950.9FALSE0.010.25
2026-01-1620PUT0 00FALSE00
2026-01-1630PUT0 100FALSE00
2026-01-1640.08PUT0 181464.74FALSE00
2026-01-1650.09PUT0 4531382.47FALSE00
2026-01-1680.05PUT0 207883.79FALSE00
2026-01-16100.05PUT0 340328.67FALSE00
2026-01-16120.05PUT0 154580.4FALSE00
2026-01-16150.05PUT1 366192.74FALSE0.020.67
2026-01-16160.63PUT0 11468.78FALSE00
2026-01-16170.8PUT0 297435.37FALSE00
2026-01-16181.15PUT0 1403.99FALSE00
2026-01-16190.11PUT0 8230.34FALSE00
2026-01-16200.05PUT0 194164.87FALSE00
2026-01-16210.4PUT0 18245.73FALSE00
2026-01-16220.1PUT0 1020145.77FALSE00
2026-01-16230.25PUT0 566123.95FALSE00
2026-01-16240.26PUT0 76108.66FALSE00
2026-01-16250.3PUT9 298093.65FALSE00
2026-01-16260.4PUT40 28187.18FALSE-0.06-0.13
2026-01-16270.52PUT28 35479.73FALSE-0.13-0.2
2026-01-16280.86PUT11 67082.32FALSE-0.09-0.09
2026-01-16291.1PUT211 172574.58FALSE-0.37-0.25
2026-01-16301.6PUT66 209575.5TRUE-0.4-0.2
2026-01-16312.4PUT3 31586.18TRUE2.40
2026-01-16322.99PUT0 28965.54TRUE00
2026-01-16333.7PUT0 53457.98TRUE00
2026-01-16345PUT6 497110.89TRUE50
2026-01-16356.05PUT2 427126.06TRUE0.270.05
2026-01-16365.82PUT0 4892.81TRUE00
2026-01-16376.34PUT0 8786.54TRUE00
2026-01-16387.24PUT0 51100.41TRUE00
2026-01-16397PUT0 31108.25TRUE00
2026-01-164010PUT0 2760TRUE00
2026-01-164111.88PUT2 15174.62TRUE11.880
2026-01-164211.5PUT0 115180.65TRUE00
2026-01-16430PUT0 0136.53TRUE00
2026-01-16440PUT0 0142.97TRUE00
2026-01-164513PUT0 0149.19TRUE00
2026-01-16460PUT0 0161.99TRUE00
2026-01-164717.93PUT0 0161.06TRUE00
2026-01-16480PUT0 0166.73TRUE00
2026-01-16490PUT0 0164.09TRUE00
2026-01-165016.6PUT0 1248240.6TRUE00
2026-01-16550PUT0 0193.39TRUE00
2026-01-16600PUT0 0188.26TRUE00
2026-02-201517CALL0 340TRUE00
2026-02-201617.18CALL0 192.58TRUE00
2026-02-20170CALL0 069.81TRUE00
2026-02-20180CALL0 061.35TRUE00
2026-02-20190CALL0 075.22TRUE00
2026-02-20209.45CALL0 308103.86TRUE00
2026-02-202110.35CALL0 2669.57TRUE00
2026-02-20228.5CALL0 20761.87TRUE00
2026-02-20237.93CALL0 1380.17TRUE00
2026-02-20248.45CALL0 9069.11TRUE00
2026-02-20255.27CALL1 18044.13TRUE5.270
2026-02-20264.5CALL1 6546.38TRUE4.50
2026-02-20275.65CALL0 22760.99TRUE00
2026-02-20283.7CALL3 14262.67TRUE0.50.16
2026-02-20293.2CALL0 8078.51TRUE00
2026-02-20302.44CALL42 80273.58FALSE0.140.06
2026-02-20311.85CALL0 40368.82FALSE00
2026-02-20321.79CALL6 14360.79FALSE1.790
2026-02-20331.32CALL27 80656.95FALSE1.320
2026-02-20341.2CALL56 52860.68FALSE0.250.26
2026-02-20350.95CALL22 47359.99FALSE0.10.12
2026-02-20360.75CALL8 33759.54FALSE0.750
2026-02-20370.45CALL2 13961.32FALSE0.450
2026-02-20380.5CALL40 43660.53FALSE0.50
2026-02-20390.72CALL0 2264.81FALSE00
2026-02-20400.3CALL19 51459.84FALSE00
2026-02-20410.75CALL0 389.34FALSE00
2026-02-20422.35CALL0 11128.77FALSE00
2026-02-20430.5CALL0 65133.16FALSE00
2026-02-20450.3CALL0 138111.66FALSE00
2026-02-20500.14CALL0 15189.16FALSE00
2026-02-20550.15CALL0 165135.47FALSE00
2026-02-20150.2PUT0 9242.58FALSE00
2026-02-20160PUT0 0232.47FALSE00
2026-02-20170.63PUT0 0216FALSE00
2026-02-20180.43PUT0 3198.42FALSE00
2026-02-20190.43PUT0 1183.93FALSE00
2026-02-20200.23PUT0 15102.07FALSE00
2026-02-20210PUT0 0164.17FALSE00
2026-02-20220.4PUT0 3157.92FALSE00
2026-02-20230.63PUT3 777.41FALSE0.630
2026-02-20240.75PUT0 7276.31FALSE00
2026-02-20251PUT0 13255.13FALSE00
2026-02-20261.13PUT0 4569.22FALSE00
2026-02-20271.4PUT4 22965.79FALSE1.40
2026-02-20281.9PUT10 28568.45FALSE1.90
2026-02-20292.5PUT0 15977.34FALSE00
2026-02-20302.65PUT33 35862.98TRUE-0.37-0.12
2026-02-20312.77PUT0 3670.17TRUE00
2026-02-20323.35PUT0 1872.59TRUE00
2026-02-20334.9PUT0 3470.94TRUE00
2026-02-20344.55PUT0 35874.42TRUE00
2026-02-20356.45PUT2 20174.58TRUE0.320.05
2026-02-20366.32PUT0 5653.94TRUE00
2026-02-20376.85PUT0 2953.06TRUE00
2026-02-20387.65PUT0 272.28TRUE00
2026-02-20397.3PUT0 656.93TRUE00
2026-02-204010.16PUT0 8174.2TRUE00
2026-02-20418.8PUT0 569.72TRUE00
2026-02-20420PUT0 073.46TRUE00
2026-02-20430PUT0 077.06TRUE00
2026-02-204514.5PUT0 46978.22TRUE00
2026-02-20500PUT0 093.04TRUE00
2026-02-20550PUT0 0106.01TRUE00
2026-05-15150CALL0 073.24TRUE00
2026-05-152012.2CALL0 35676.87TRUE00
2026-05-152310.16CALL0 4781.12TRUE00
2026-05-15248.2CALL0 15882.09TRUE00
2026-05-15258CALL0 32974.61TRUE00
2026-05-15266.6CALL0 26476.38TRUE00
2026-05-15278CALL0 770.38TRUE00
2026-05-15286.05CALL0 1971.92TRUE00
2026-05-15295.14CALL1 13064.63TRUE0.040.01
2026-05-15304.7CALL0 37475.52FALSE00
2026-05-15314.2CALL0 4271.24FALSE00
2026-05-15324.4CALL57 15771.6FALSE0.50.13
2026-05-15333.75CALL8 7667.36FALSE3.750
2026-05-15343.9CALL0 1773.3FALSE00
2026-05-15353.2CALL0 11080.34FALSE00
2026-05-15362.5CALL0 2772.6FALSE00
2026-05-15373.01CALL0 666.48FALSE00
2026-05-15382.51CALL0 1980.12FALSE00
2026-05-15393CALL0 2669.33FALSE00
2026-05-15401.73CALL1 9871.21FALSE-0.07-0.04
2026-05-15412.21CALL0 1866.89FALSE00
2026-05-15421.3CALL0 2270.81FALSE00
2026-05-15451CALL10 26769.41FALSE0.020.02
2026-05-15500.57CALL0 18664.84FALSE00
2026-05-15550.53CALL0 6888.58FALSE00
2026-05-15150.31PUT0 2139.35FALSE00
2026-05-15200.97PUT0 1274.92FALSE00
2026-05-15232.05PUT1 1977.89FALSE0.080.04
2026-05-15242.3PUT0 10381.1FALSE00
2026-05-15252.4PUT0 2174.73FALSE00
2026-05-15263PUT10 9273.37FALSE30
2026-05-15272.98PUT0 1081.82FALSE00
2026-05-15284.04PUT0 1470.2FALSE00
2026-05-15294.2PUT0 322875.02FALSE00
2026-05-15305.01PUT6 28972.82TRUE0.110.02
2026-05-15314.7PUT0 13674.97TRUE00
2026-05-15325.13PUT0 2074.69TRUE00
2026-05-15336.35PUT0 064.19TRUE00
2026-05-15347.3PUT0 277.99TRUE00
2026-05-15357.4PUT0 1170.99TRUE00
2026-05-15367.2PUT0 179.31TRUE00
2026-05-15377.7PUT0 1069.37TRUE00
2026-05-15380PUT0 068.4TRUE00
2026-05-15398.7PUT0 1673.24TRUE00
2026-05-154011.8PUT10 2069.38TRUE-0.22-0.02
2026-05-154112.97PUT2 775.07TRUE12.970
2026-05-15420PUT0 066.72TRUE00
2026-05-154515.1PUT0 367.66TRUE00
2026-05-155020.13PUT0 20066.2TRUE00
2026-05-15550PUT0 069.8TRUE00
2026-08-212012CALL0 1569.86TRUE00
2026-08-21220CALL0 067.29TRUE00
2026-08-212311.72CALL0 166.68TRUE00
2026-08-21240CALL0 065.02TRUE00
2026-08-21250CALL0 064.45TRUE00
2026-08-21268.05CALL0 9861.68TRUE00
2026-08-21278.54CALL0 162.99TRUE00
2026-08-21287.8CALL0 162.12TRUE00
2026-08-21297.59CALL0 661.54TRUE00
2026-08-21306.95CALL0 660.69FALSE00
2026-08-21310CALL0 060.13FALSE00
2026-08-21325.79CALL0 159.85FALSE00
2026-08-21335.5CALL0 1361.97FALSE00
2026-08-21344.6CALL0 1060.39FALSE00
2026-08-21354.4CALL0 564.95FALSE00
2026-08-21360CALL0 059.47FALSE00
2026-08-21370CALL0 060.97FALSE00
2026-08-21380CALL0 061.76FALSE00
2026-08-21393.68CALL0 1561.56FALSE00
2026-08-21404.15CALL0 654.38FALSE00
2026-08-21452.3CALL0 159.93FALSE00
2026-08-21201.7PUT0 762.4FALSE00
2026-08-21220PUT0 064.01FALSE00
2026-08-21232.5PUT0 354.1FALSE00
2026-08-21243.05PUT0 367.81FALSE00
2026-08-21250PUT0 063.42FALSE00
2026-08-21263.5PUT0 165.9FALSE00
2026-08-21273.9PUT0 164.84FALSE00
2026-08-21280PUT0 063.22FALSE00
2026-08-21290PUT0 062.5FALSE00
2026-08-21305.5PUT0 562.34TRUE00
2026-08-21316.08PUT0 461.9TRUE00
2026-08-21320PUT0 062.27TRUE00
2026-08-21330PUT0 062.38TRUE00
2026-08-21340PUT0 062.24TRUE00
2026-08-21350PUT0 061.33TRUE00
2026-08-21360PUT0 060.19TRUE00
2026-08-21370PUT0 060.99TRUE00
2026-08-21380PUT0 061.05TRUE00
2026-08-21390PUT0 060.92TRUE00
2026-08-21400PUT0 060.58TRUE00
2026-08-21450PUT0 059TRUE00
2027-01-151317.4CALL0 17480.32TRUE00
2027-01-151517CALL1 63578.98TRUE0.070
2027-01-151813.87CALL0 14764.13TRUE00
2027-01-152012.68CALL4 63961.58TRUE0.310.03
2027-01-152212.09CALL87 69468.83TRUE0.690.06
2027-01-15259.8CALL0 73665.38TRUE00
2027-01-15279.19CALL2 20863.98TRUE9.190
2027-01-15306.77CALL0 41456.35FALSE00
2027-01-15327.5CALL0 10958.03FALSE00
2027-01-15356.09CALL24 233762.27FALSE0.490.09
2027-01-15375.5CALL0 20355.82FALSE00
2027-01-15404.5CALL61 90159.85FALSE0.40.1
2027-01-15424.3CALL0 6859.67FALSE00
2027-01-15453.71CALL0 102261.51FALSE00
2027-01-15472.9CALL2 30657.33FALSE-0.1-0.03
2027-01-15502.32CALL0 63654.35FALSE00
2027-01-15552.01CALL0 18157.35FALSE00
2027-01-15602CALL0 157658.52FALSE00
2027-01-15131.12PUT0 37135.94FALSE00
2027-01-15151.23PUT0 10165.19FALSE00
2027-01-15182.15PUT0 6983.15FALSE00
2027-01-15202.53PUT0 11366.54FALSE00
2027-01-15223.35PUT0 12465.15FALSE00
2027-01-15254.45PUT4 157064.47FALSE4.450
2027-01-15275.5PUT0 10861.84FALSE00
2027-01-15306.45PUT0 27056.69TRUE00
2027-01-15328.21PUT0 1862.13TRUE00
2027-01-15359.3PUT0 171362.27TRUE00
2027-01-153710.41PUT0 1460.56TRUE00
2027-01-154013.33PUT0 19158.69TRUE00
2027-01-154214.32PUT0 17258.25TRUE00
2027-01-154517.1PUT0 49156.67TRUE00
2027-01-15470PUT0 057.89TRUE00
2027-01-155021.2PUT0 34057.69TRUE00
2027-01-155525.2PUT0 7058.85TRUE00
2027-01-156029.5PUT0 1257.29TRUE00
2028-01-211518.4CALL0 471.56TRUE00
2028-01-212016.2CALL0 4562.48TRUE00
2028-01-212313.88CALL60 064.37TRUE13.880
2028-01-212514.6CALL0 20262.04TRUE00
2028-01-212812.6CALL0 4061.32TRUE00
2028-01-213010.7CALL1 11460.62FALSE10.70
2028-01-213213.6CALL0 28760.6FALSE00
2028-01-213510.81CALL0 3659.55FALSE00
2028-01-21370CALL0 059.77FALSE00
2028-01-21408.6CALL0 1358.16FALSE00
2028-01-21420CALL0 057.84FALSE00
2028-01-21456.2CALL0 94458.18FALSE00
2028-01-21505.23CALL0 14248.75FALSE00
2028-01-21556CALL0 2555.8FALSE00
2028-01-21150PUT0 070.27FALSE00
2028-01-21204.3PUT0 863.64FALSE00
2028-01-21230PUT0 063.99FALSE00
2028-01-21256.2PUT0 464.23FALSE00
2028-01-21288.5PUT0 361.92FALSE00
2028-01-21309.7PUT0 10057.85TRUE00
2028-01-21329.75PUT0 061.99TRUE00
2028-01-213512.47PUT0 058.85TRUE00
2028-01-213712.27PUT0 359.52TRUE00
2028-01-214013PUT0 1558.52TRUE00
2028-01-21420PUT0 058.55TRUE00
2028-01-214518PUT0 156.61TRUE00
2028-01-215023.3PUT0 6956.48TRUE00
2028-01-215526.29PUT0 454.91TRUE00

Latest TGTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST987$4.135
Jun 13, 2022 7:59 PM EST93$4.14
Jun 13, 2022 7:59 PM EST1$4.14
Jun 13, 2022 7:59 PM EST10$4.14
Jun 13, 2022 7:59 PM EST200$4.135

TG Therapeutics, Inc (TGTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1001316/000000000018021923/0000000000-18-021923-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375119000238/0000093751-19-000238-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000009375120000475/0000093751-20-000475-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719006548/0000215457-19-006548-index.htm
2019-06-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000021545719008047/0000215457-19-008047-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506618001636/0000315066-18-001636-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506619001380/0000315066-19-001380-index.htm
2020-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000031506620001583/0000315066-20-001583-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000083423720008183/0000834237-20-008183-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266419001008/0000902664-19-001008-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000090266420001111/0000902664-20-001111-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920021910/0001104659-20-021910-index.htm
2020-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920058131/0001104659-20-058131-index.htm
2020-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920072021/0001104659-20-072021-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2020-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080593/0001104659-20-080593-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000110465920092406/0001104659-20-092406-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-05-31PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036119010173/0001140361-19-010173-index.htm
2020-05-29PX14A6GNotice of exempt solicitation submitted by non-managementhttps://www.sec.gov/Archives/edgar/data/1001316/000114036120012674/0001140361-20-012674-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000114420419008306/0001144204-19-008306-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266118000780/0001172661-18-000780-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000823/0001172661-19-000823-index.htm
2019-03-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266119000927/0001172661-19-000927-index.htm
2020-01-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000001/0001172661-20-000001-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000117266120000786/0001172661-20-000786-index.htm
2018-06-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518195773/0001193125-18-195773-index.htm
2018-07-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1001316/000119312518215834/0001193125-18-215834-index.htm
2019-03-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924419000034/0001319244-19-000034-index.htm
2020-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1001316/000131924420000018/0001319244-20-000018-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000155837020001897/0001558370-20-001897-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020001925/0001558370-20-001925-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020002992/0001558370-20-002992-index.htm
2020-03-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020002997/0001558370-20-002997-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004647/0001558370-20-004647-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004651/0001558370-20-004651-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020004722/0001558370-20-004722-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020005097/0001558370-20-005097-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006304/0001558370-20-006304-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006314/0001558370-20-006314-index.htm
2020-05-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006630/0001558370-20-006630-index.htm
2020-05-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020006795/0001558370-20-006795-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020006811/0001558370-20-006811-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020007744/0001558370-20-007744-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000155837020010225/0001558370-20-010225-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000155837020012661/0001558370-20-012661-index.htm
2018-02-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418001025/0001654954-18-001025-index.htm
2018-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418002262/0001654954-18-002262-index.htm
2018-03-1510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495418002638/0001654954-18-002638-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004295/0001654954-18-004295-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004519/0001654954-18-004519-index.htm
2018-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004521/0001654954-18-004521-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418004821/0001654954-18-004821-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418005046/0001654954-18-005046-index.htm
2018-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006261/0001654954-18-006261-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006381/0001654954-18-006381-index.htm
2018-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006609/0001654954-18-006609-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006703/0001654954-18-006703-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006743/0001654954-18-006743-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006777/0001654954-18-006777-index.htm
2018-06-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418006935/0001654954-18-006935-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2018-07-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495418007460/0001654954-18-007460-index.htm
2018-07-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1001316/000165495418007816/0001654954-18-007816-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418008559/0001654954-18-008559-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418008750/0001654954-18-008750-index.htm
2018-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418010436/0001654954-18-010436-index.htm
2018-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418011171/0001654954-18-011171-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418012263/0001654954-18-012263-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495418012303/0001654954-18-012303-index.htm
2018-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495418013524/0001654954-18-013524-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419000641/0001654954-19-000641-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002047/0001654954-19-002047-index.htm
2019-02-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002091/0001654954-19-002091-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002189/0001654954-19-002189-index.htm
2019-03-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419002274/0001654954-19-002274-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419002276/0001654954-19-002276-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419003766/0001654954-19-003766-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005036/0001654954-19-005036-index.htm
2019-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005037/0001654954-19-005037-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005419/0001654954-19-005419-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419005592/0001654954-19-005592-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419005680/0001654954-19-005680-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007297/0001654954-19-007297-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2019-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419009109/0001654954-19-009109-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419009176/0001654954-19-009176-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1001316/000165495419010203/0001654954-19-010203-index.htm
2019-09-05RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010400/0001654954-19-010400-index.htm
2019-09-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010402/0001654954-19-010402-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010620/0001654954-19-010620-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012023/0001654954-19-012023-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419012611/0001654954-19-012611-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419012751/0001654954-19-012751-index.htm
2019-12-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419013703/0001654954-19-013703-index.htm
2019-12-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1001316/000165495419014167/0001654954-19-014167-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1001316/000165495419014209/0001654954-19-014209-index.htm
2018-07-23EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1001316/999999999518001856/9999999995-18-001856-index.htm
2018-04-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718005345/9999999997-18-005345-index.htm
2018-09-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1001316/999999999718007926/9999999997-18-007926-index.htm

TG Therapeutics, Inc (TGTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of TG Therapeutics, Inc (TGTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 713%
Institutional Ownership: 6724%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-09-17WILLIAM JAMES KENNEDYDirectorBuy27,048.00102,378.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010886/0001654954-19-010886-index.htm
2020-06-22WILLIAM JAMES KENNEDYDirectorBuy15,000.00109,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm
2018-06-26MICHAEL S WEISSCEO and PresidentBuy1,018,011.0011,648,805.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/0001654954-18-007119-index.htm
2018-06-26Kenneth HobermanDirectorBuy15,000.00116,905.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007121/0001654954-18-007121-index.htm
2018-06-26Yann EchelardDirectorBuy15,000.00117,068.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007116/0001654954-18-007116-index.htm
2018-06-26Laurence N CharneyDirectorBuy15,000.00118,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007267/0001654954-18-007267-index.htm
2019-09-17DANIEL HUMEDirectorBuy27,048.00119,507.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010885/0001654954-19-010885-index.htm
2018-06-26MARK SCHOENEBAUMDirectorBuy15,000.00125,949.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007117/0001654954-18-007117-index.htm
2020-09-09RA CAPITAL MANAGEMENT, L.P.10% Share HolderSell158,589.0025.814,092,738.0412,629,868.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920104436/0001104659-20-104436-index.htm
2019-06-13MICHAEL S WEISSCEO and PresidentBuy1,179,380.0012,828,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/0001654954-19-007359-index.htm
2019-06-26MICHAEL S WEISSCEO and PresidentBuy50,000.007.04351,750.0012,878,185.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/0001654954-19-007706-index.htm
2020-06-22DANIEL HUMEDirectorBuy15,000.00134,507.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076546/0001104659-20-076546-index.htm
2019-09-17Kenneth HobermanDirectorBuy27,048.00143,953.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010891/0001654954-19-010891-index.htm
2019-09-17Yann EchelardDirectorBuy27,048.00144,116.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010888/0001654954-19-010888-index.htm
2020-06-22MICHAEL S WEISSCEO and PresidentBuy1,556,029.0014,434,214.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/0001104659-20-076547-index.htm
2019-09-17Laurence N CharneyDirectorBuy27,048.00145,997.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419010890/0001654954-19-010890-index.htm
2020-06-22Kenneth HobermanDirectorBuy15,000.00158,953.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076545/0001104659-20-076545-index.htm
2020-06-22Yann EchelardDirectorBuy15,000.00159,116.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076544/0001104659-20-076544-index.htm
2020-06-22Laurence N CharneyDirectorBuy15,000.00160,997.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076543/0001104659-20-076543-index.htm
2019-07-01Sean A PowerCFO, Secretary and TreasurerSell17,654.008.47149,529.38383,338.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419007935/0001654954-19-007935-index.htm
2019-01-02Sean A PowerCFO, Secretary and TreasurerSell37,275.004.13153,945.75400,992.00https://www.sec.gov/Archives/edgar/data/1001316/000165495419000085/0001654954-19-000085-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy50,000.00433,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2018-07-03Sean A PowerCFO, Secretary and TreasurerSell35,000.0013.19461,650.00438,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-07-02Sean A PowerCFO, Secretary and TreasurerSell12,191.0013.26161,652.66473,267.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007370/0001654954-18-007370-index.htm
2018-06-14WILLIAM JAMES KENNEDYDirectorSell25,071.0013.45337,204.9560,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418006742/0001654954-18-006742-index.htm
2020-07-16Sean A PowerCFO, Secretary and TreasurerBuy200,000.00633,338.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920084949/0001104659-20-084949-index.htm
2020-06-22Sagar LonialDirectorBuy65,000.0065,000.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920080595/0001104659-20-080595-index.htm
2018-06-26WILLIAM JAMES KENNEDYDirectorBuy15,000.0075,330.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007120/0001654954-18-007120-index.htm
2018-06-26DANIEL HUMEDirectorBuy15,000.0092,459.00https://www.sec.gov/Archives/edgar/data/1001316/000165495418007118/0001654954-18-007118-index.htm
2020-06-17WILLIAM JAMES KENNEDYDirectorSell7,745.0018.27141,501.1594,633.00https://www.sec.gov/Archives/edgar/data/1001316/000110465920076542/0001104659-20-076542-index.htm